Sensitive and rapid method for the simultaneous quantification of the HIV-protease inhibitors indinavir, nelfinavir, ritonavir, and saquinavir in human plasma by reversed-phase liquid chromatography
M. Bouley et al., Sensitive and rapid method for the simultaneous quantification of the HIV-protease inhibitors indinavir, nelfinavir, ritonavir, and saquinavir in human plasma by reversed-phase liquid chromatography, THER DRUG M, 23(1), 2001, pp. 56-60
A rapid, sensitive, and specific liquid chromatography method for the simul
taneous determination of four protease inhibitors (indinavir, nelfinavir, r
itonavir, and saquinavir) in human plasma is described. After a liquid-liqu
id extraction with terbutyl methyl ether and a sequential washing of the re
constituted sample with hexane, protease inhibitors are separated on a phen
yl column using a simple binary mobile phase of ammonium acetate buffer:ace
tonitrile (48:52) (pH = 7.5) with an ultraviolet detection at 260 nm. The s
tandard curves are linear in the range 0.025-1 mug/mL for saquinavir. 0.1-4
mug/mL for indinavir and nelfinavir, and 0.25-10 mug/mL for ritonavir, wit
h an average recovery ranging from 79% to 99%, and with both low interday a
nd intraday coefficients of variation (<15%). This assay is simple, rapid (
15-minute interval between runs). and useful for therapeutic monitoring of
the protease inhibitors on a routine basis.